AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Establishment Labs Holdings Inc.
XNAS · usd
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG00L8R3DH5
63.80▲ 0.28 (0.44%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
63.52
Day's Range
62.85 – 64.94
52-Week Range
47.00 – 97.59
Volume
346.2K
Avg Volume
366.7K
Share Statistics
Shares Outstanding
Employees
1,004
Exchange
XNAS
Listed
2018-07-19
Share count as of August 6, 2026

Establishment Labs Holdings Inc. (ESTA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Establishment Labs Holdings Inc. (ESTA)
What is Establishment Labs Holdings Inc.'s Market Cap?
Establishment Labs Holdings Inc.'s Market Cap is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s Enterprise Value?
Establishment Labs Holdings Inc.'s Enterprise Value is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s Price / Sales?
Establishment Labs Holdings Inc.'s Price / Sales is 7.7×, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s EV / Revenue?
Establishment Labs Holdings Inc.'s EV / Revenue is 8.5×, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s EV / EBITDA?
Establishment Labs Holdings Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s Revenue (TTM)?
Establishment Labs Holdings Inc.'s Revenue (TTM) is $245.8M, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s Net Income (TTM)?
Establishment Labs Holdings Inc.'s Net Income (TTM) is -$38.9M, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s EBITDA?
Establishment Labs Holdings Inc.'s EBITDA is -$12.6M, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s Diluted EPS (TTM)?
Establishment Labs Holdings Inc.'s Diluted EPS (TTM) is -1.30, based on as-reported figures from SEC (XBRL) filings.
What is Establishment Labs Holdings Inc.'s EBITDA Margin?
Establishment Labs Holdings Inc.'s EBITDA Margin is -5.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ESTAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+31.7%+44.7%+45.2%+33.7%
Cost of revenue
Gross profit
% of revenue70.6%70.7%70.5%70.1%
Operating expenses:
Sales, general and administrative
Research and development
Total operating expenses
% of revenue77.0%81.6%76.5%77.6%
Loss from operations
% of revenue-6.4%-10.9%-6.1%-7.5%
Interest income
Interest expense
Other (income) loss, net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-17.4%-22.3%-4.0%-20.7%
Basic net loss per share (in dollars per share)
Diluted net loss per share (in dollars per share)